AstriVax Therapeutics is a clinical-stage biopharmaceutical company focused on developing virus-targeted immunotherapies to combat virus-driven cancers, particularly those caused by human papillomavirus (HPV)
AstriVax Therapeutics is a clinical-stage biopharmaceutical company focused on developing virus-targeted immunotherapies to combat virus-driven cancers, particularly those caused by human papillomavirus (HPV). Their Launch-iT platform aims to generate durable T-cell responses to clear virus-infected cells.